Tigapotide

Tax included
Tigapotide (PCK-3145) is an anti-tumour peptide that reduces the development of skeletal metastases associated with prostate cancer. Tigapotide induces apoptosis and reduces tumour parathyroid hormone-related peptide (PTHrP) levels.
HY-16498

Data sheet

Size
Multiple sizes
Reactivity
Apoptosis
Application
Cancer-programmed cell death
CAS
848084-83-3